Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Relevance of Fast Track Integrative Approaches for the Control of COVID-19


Affiliations
1 Managing Director, Pharmanza Herbal Pvt. Ltd. Gujarat, India
2 CEO, Synergia Life Sciences Pvt. Ltd. Mumbai, India
3 Director, Division of Endocrine and Metabolic Disorders, Medical and Research Centre - Kasturba Health Society, Mumbai, India
4 Research Director, Kasturba Health Society-Medical Research Centre, Mumbai, India
     

   Subscribe/Renew Journal


The current global pandemic of COVID-19 has spread over 212 countries with marked morbidity and substantial mortality. This has resulted in colossal burden on the worldwide healthcare system. Globally the management of this new disease is primarily supportive and resuscitative. Vaccine and anti-COVID-19 drugs are still under development. Oriental medicine of India and China and the medicinal plants offer a potential for a fast track development of phytopharmaceuticals. In the present overview we have shortlisted the following Indian medicinal plants, based on their traditional usage and scientific rationale: Phyllanthus amarus Schum and Thonn., Berberis aristata DC., Swertia chirata and Androgaphis paniculata (Burm. f.). These medicinal plants and the phytoactives can be rapidly evaluated for anti-COVID-19 activity through reverse pharmacology.

Keywords

COVID-19, Reverse Pharmacology, Medicinal Plants, Antiviral Activity, Phytopharmaceuticals.
Subscription Login to verify subscription
User
Notifications
Font Size



  • Relevance of Fast Track Integrative Approaches for the Control of COVID-19

Abstract Views: 301  |  PDF Views: 1

Authors

Lal Hingorani
Managing Director, Pharmanza Herbal Pvt. Ltd. Gujarat, India
Dilip Mehta
CEO, Synergia Life Sciences Pvt. Ltd. Mumbai, India
Rama Vaidya
Director, Division of Endocrine and Metabolic Disorders, Medical and Research Centre - Kasturba Health Society, Mumbai, India
Ashok B. Vaidya
Research Director, Kasturba Health Society-Medical Research Centre, Mumbai, India

Abstract


The current global pandemic of COVID-19 has spread over 212 countries with marked morbidity and substantial mortality. This has resulted in colossal burden on the worldwide healthcare system. Globally the management of this new disease is primarily supportive and resuscitative. Vaccine and anti-COVID-19 drugs are still under development. Oriental medicine of India and China and the medicinal plants offer a potential for a fast track development of phytopharmaceuticals. In the present overview we have shortlisted the following Indian medicinal plants, based on their traditional usage and scientific rationale: Phyllanthus amarus Schum and Thonn., Berberis aristata DC., Swertia chirata and Androgaphis paniculata (Burm. f.). These medicinal plants and the phytoactives can be rapidly evaluated for anti-COVID-19 activity through reverse pharmacology.

Keywords


COVID-19, Reverse Pharmacology, Medicinal Plants, Antiviral Activity, Phytopharmaceuticals.

References